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Study Objectives: To identify cross-sectional and seasonal patterns of sleep and physical activity (PA) in community-dwelling, older Icelandic adults using 
accelerometers.
Methods: A seven-day free-living protocol of 244 (110 female) adults aged 79.7 ± 4.9 years was conducted as part of a larger population-based longitudinal 
observational-cohort study in the greater Reykjavik area of Iceland. A subpopulation (n = 72) repeated the 7-day measurement during seasonal periods with 
greater (13.4 ± 1.4 h) and lesser (7.7 ± 1.8 h) daylight.
Results: Cross-sectional analyses using multiple linear regression models revealed that day length was a significant independent predictor of sleep duration, 
mid-sleep, and rise time (all p < 0.05). However, the actual within-individual differences in sleep patterns of the repeaters were rather subtle between periods 
of longer and shorter day-lengths. Compared to women, men had a shorter sleep duration (462 ± 80 vs. 487 ± 68 minutes, p = 0.008), earlier rise time, and 
a greater number of awakenings per night (46.5 ± 18.3 vs. 40.2 ± 15.7, p = 0.007), but sleep efficiency and onset latency were similar between the two sexes. 
Daily PA was also similar between men and women and between periods of longer and shorter day-lengths. BMI, age, gender, and overall PA all contributed 
to the variations in sleep parameters using multiple regression analysis.
Conclusions: The sleep and PA characteristics of this unique population revealed some gender differences, but there was limited variation in response to 
significant daylight changes which may be due to long-term adaptation.
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INTRODUCTION
The importance of sleep to physical and metabolic health is 
well documented.1,2 Although sleep needs are thought to be 
independent of age, older people often have more sleep prob-
lems, such as premature awakening, fragmented sleep patterns, 
and reduced depth of sleep.3–5 Poor sleep quality among older 
adults has been associated with declines in both physical and 
mental function and increased risk of all-cause-mortality.2,6–9 
Thus, it is important to identify factors that may influence both 
the duration and the quality of sleep in older adults.
The causes for reduced sleep duration and quality in older 
people are not clear. There is some evidence to suggest that 
circadian regulation of sleep weakens with age,3 resulting in 
reduced sleep consolidation and changes in sleep-wake tim-
ing.10 However, additional factors, such as the response to vari-
ous environmental cues could also play a role. For example, 
external environmental factors, particularly variations in ar-
tificial light exposure and day length, have been shown to in-
fluence sleep patterns and quality.11–15 Increased exposure to 
artificial light has been shown to increase sleep disturbances11 
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and prolong sleep onset latency in an older population.12 Simi-
larly, increased light exposure in laboratory settings has been 
show to elicit similar circadian shifts in younger and older 
adult populations,13 but older adults appear to have blunted 
responses to lower light levels13 and blue light exposure.16,17 
Reduced daylight exposure due to change of season has also 
been shown to prolong the onset of sleep14 and cause shifts in 
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bed- and rise-times14 in younger adult populations. But day 
length has not been shown to have a dramatic effect on the 
quality of sleep,14 and observations of its influence on sleep 
duration have been mixed.14,15
It is also plausible that changes in physical activity (PA) pat-
terns may contribute to reduced quality and duration of sleep 
in older adults. Increased PA is thought to lead to reduced sleep 
disturbances18, but PA is known to decline with age,19–21 and this 
trend may contribute to the reduced sleep quality reported by 
older individuals. Very few studies have simultaneously cap-
tured objectively measured sleep and PA data in older popula-
tions,22 and little is known about the interaction of day length 
and physical activity on sleep patterns in older individuals.
The primary goal of this study was to delineate the poten-
tial effects of day length, objectively measured PA, and other 
subject characteristics on sleep quality and patterns measured 
by wrist actigraphy in a group of generally healthy, commu-
nity-dwelling, elderly Icelandic population. Iceland is known 
to have one of the world’s highest life expectancies—currently 
82 years—as well as one of the highest healthy life expectan-
cies, or the number of years a person can expect to live in full 
health, as defined by the World Health Organization (WHO).23 
Iceland’s unique geographical location (latitude 64–66°North) 
results in a wide variation in daylight hours, 4–21 hours be-
tween winter and summer months. This large seasonal varia-
tion in daylight hours offered an ideal opportunity to study the 
impact of daylight length on the objectively measured sleep 
and PA in a population of older adults.
METHODS
Study Population
The Age, Gene/Environment Susceptibility (AGES)-Reykja-
vik Study was designed to assess the influence of environment, 
genetic factors, and gene-environment interaction on various 
health topics related to aging in a historically healthy, aging 
population with high life expectancy.24 The study was initiated 
with a first wave of data collection from 2002–2006 with 5,764 
participants who were recruited from the original Reykjavik 
Study which has collected data on age-related topics since 
1967.24 The second wave of data collection (AGESII-Reykja-
vik) involving 3,411 participants took place between 2007 and 
2011. A sub-study involving objectively measured, free-living 
PA and sleep using accelerometers occurred between April 
2009 and June 2010. Further details of the AGES-Reykjavik 
study design and assessment can be found elsewhere.24
From a total of 1,194 people participated in the AGESII-
Reykjavik study over the period in which PA were measured, 
completed data was successfully collected from 654 partici-
pants, all of whom did not have cognitive impairment (Mini 
Mental State Examination score > 20) or physical obstruc-
tions (e.g., blindness). A flow chart for this study population is 
shown in Figure 1. A detailed analysis of the PA patterns in 
this population has been previously described.25
Two hundred sixty-three of the remaining 654 participants 
were given wrist-worn accelerometer for sleep assessment, due 
to the limited availability of the devices. The 244 participants 
with ≥ 4 valid days (≥ 10 h wear time)21 of hip-worn PA data 
were used in the final cross-sectional analysis. Four of the sub-
jects failed to answer a questionnaire related to health status 
and were excluded from any multivariate analyses which used 
this as a covariate. This group of subjects formed the basis 
for our cross-sectional data analyses to explore the between-
individual differences of sleep quality and patterns, and their 
associations to subject characteristics, environmental factors, 
and PA measures.
Understanding the limitations of cross-sectional analysis, 
we designed a further examination to study the influence of 
day length on within-individual changes in patterns of sleep 
and PA. Thus, we asked a subsample of 72 subjects whose mea-
surement period began between August 1, 2009, and October 1, 
2009, to repeat the measurements of sleep and PA during a 
period with fewer daylight hours occurring between January 1, 
2010, and March 18, 2010. Two hip worn PA monitor device 
failures occurred during the repeat measurement, leaving 70 
subjects with valid sleep assessment data and at least 1 day of 
valid hip-worn PA data during seasonal periods of greater and 
lesser hours of daylight.
All participants provided informed consent and the study 
was approved by the Icelandic National Bioethics Committee 
(VSN: 00–063), the Icelandic Data Protection Authority, and 
the institutional review board of the US National Institute on 
Aging, National Institutes of Health.
Demographic and Environmental Parameters
Participants came to the Icelandic Heart Association in Kópa-
vogur, Iceland for assessment of cognitive and physical func-
tion as part of the AGESII-Reykjavik study. Height and weight 
were taken using standardized procedures and body mass in-
dex (BMI) was computed as the ratio weight/height2 (kg/m2). 
Participants reported overall health status on a discrete scale 
(1-excellent, 2-very good, 3-good, 4-fair, 5-poor) and whether 
or not they had been diagnosed with depression in the past 5 
years (0-no, 1-yes, 8-not sure) as part of a comprehensive series 
of health history questionnaires administered to all AGESII 
participants.24 Subjects were also asked to report all medica-
tion used in the two weeks prior to their visit. The hours of 
daylight and over each participant’s week of free-living mea-
surement were obtained using the Sunrise/Sunset calculator 
provided by the Earth System Research Laboratory of the Na-
tional Oceanic and Atmospheric Administration (http://www.
esrl.noaa.gov/gmd/grad/solcalc/calcdetails.html). The average 
daily outdoor temperature over the same period was obtained 
from the Weather Underground (www.wunderground.com) 
historical weather data.
Sleep Measurements
Participants were given actigraphy-based sleep watches (Ac-
tiwatch Spectrum, Phillips-Respironics, Bend OR) to wear on 
the non-dominant wrist for 7-day free living sleep assessment. 
The watches contain motion-sensitive accelerometers which 
have been previously validated for objective sleep measure-
ment.26 Each watch was programmed to record wrist-activity 
and white-light intensity in 15-sec epochs. Rest and sleep 
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software27 (Actiware version 4.0) and visually inspected and 
compared to the hip PA monitor non-wear events and the 
hand-written sleep diary that each subject kept. For sleep 
analysis, the wake threshold of the actiwatch data was set 
medium (40 activity counts), sleep onset and end were both 
set to 10 minutes, and white light threshold was 1000 lux. 
The following parameters were reported for each sleep event 
over the 7-day period using the Actiware software27: bedtime 
(start of the rest period, time subject gets in bed), rise time 
(end of the rest period, time subject gets out of bed), rest dura-
tion (rise time minus bed time), sleep duration (time within 
the rest period that was scored as sleep), onset latency (sleep 
onset time minus bed time), number of awakenings during 
sleep period, minutes of waking after sleep onset (WASO), 
mid-sleep time (midpoint between bed time and rise time), 
and sleep efficiency (percent of rest period that participant 
was scored as sleep). Further, the white light intensity was 
averaged over each complete day and for each rest and sleep 
period. Fifty-three different sleep watches were used over the 
course of the study.
Physical Activity Measurement
Accelerometry-based PA monitors (Actigraph GT3X, Acti-
graph LLC, Pensacola, FL) were worn on the right hip through-
out the 7-day free-living period. They were used to record PA 
intensity, computed as manufacturer specific activity counts in 
the vertical plane of motion, on a second-by-second basis and 
accumulated over each valid day of PA-accelerometer wear. 
The daily PA activity count totals provide similar PA inten-
sity information as those found in other large epidemiologic 
studies of free-living PA, including the National Health and 
Nutrition Examination Survey (NHANES)21 and the larger 
cross-sectional analysis of PA in the AGES II cohort.25 Par-
ticipants were told to remove the device before going to bed at 
night and before showering, bathing, or other water activities. 
Periods of non-wear were also automatically detected using a 
previously described method, 60 minutes or more of consecu-
tive zero activity counts, allowing 1–2 minutes < 100 activ-
ity counts.21 A technician reviewed the diary and all detected 
non-wear periods with each participant using customized visu-
alization software (Matlab version 2006, The Mathworks Inc, 
Natick, MA). Days with < 10 h of wear-time were considered 
invalid.21 Ninety-two different Actigraph accelerometers were 
used over the course of the study.
Statistical Methods
All descriptive data were reported in mean and standard de-
viation. Data were organized by a customized Matlab pro-
gram, and statistical analyses were performed using R (version 
3.1.0; http://www.r-project.org/). The significance level was 
set at p < 0.05 and two-sided. Normality of each variable was 
checked and confirmed using Q-Q plots before analyses.
Figure 1—Flow chart describing participants recruited from the AGES II-Reykjavik Study for cross-sectional and repeated visit 
analysis of sleep and activity patterns.
Used for Repeated Analyses
 ≥ 4 Valid Days of Physical Activity Data (n = 244)
Repeated Physical Activity and Sleep Monitoring during 
Periods of Greater and Lesser Day Length (n = 72)
Used for Cross-sectional Analyses
April 2009–June 2010
Limited availability of sleep watches
Completed Physical Activity and Sleep Monitoring (n = 263)
Completed Physical Activity Monitoring (n = 654)
Sub-study Measuring Free-living Physical Activity and Sleep (n = 1,194)
AGES II-Reykjavik Study Participants from 2007–2011 (n = 3,411)
Did Not Complete Physical Activity Monitoring (n = 540)
• Refused (84)
• Excluded (150)
• Cognitively Impaired (55)
• Physical Obstruction (95)
• Schedule Conflicts (294)
• Device Failures (12)
• Lost Monitors (n = 5)
Only Completed Physical Activity Monitoring (n = 391)
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Cross-Sectional Analysis
Spearman correlations were used to identify potential relation-
ships between sleep measures, subject demographics, and PA 
measures. To preserve sufficient power, only those measures 
achieving Spearman correlation coefficients with the signifi-
cance (p < 0.05) were selected to enter the stepwise, multivari-
ate regression to further explore the relationship between sleep 
parameters, gender, PA, and day length. Separate multiple 
linear regression models were evaluated using sleep duration, 
rest duration, sleep efficiency, onset latency, WASO, number 
awakenings, and sleep midpoint time as independent response 
variables while age, sex, BMI, self-reported health status, to-
tal activity counts per wear time minute, outdoor temperature, 
diagnosed depression, and day length were used as covariates 
in each of the regression models. The use of antidepressants, 
benzodiazepines, and all other sleep medications were com-
bined into one variable and used as a covariate in the regres-
sion models. Backward-elimination regression analysis was 
used to identify significant, independent predictors for each of 
the sleep parameters listed. Covariates with significance at or 
below 0.10 were retained during each step of the analysis.
Within-Individual Visits
Comparisons between the environmental and physical activity 
variables acquired during periods of long and short day lengths 
were performed using paired t-tests. Linear mixed models with 
random intercepts were used to compare sleep parameters col-
lected over 2 measurement periods separated by 147 ± 18 days 
on average. Each sleep parameter served as a response vari-
able in separate models. Subject identification was the random 
effects variable in each model. Other covariates of BMI, age, 
gender, self-reported health status, diagnosis of depression, 
sleep medication usage, and day length were included as fixed 




Characteristics of the study participants were presented in 
Table 1. The study population had an average age of 79.5 ± 4.8 
years and BMI of 26.9 ± 4.7 kg/m2. Over 70% of the partici-
pants self-reported to be in good health or better, while less 
than 3% of participants reported to have poor health status. 
The daily hours of daylight over the study period varied widely, 
from 4.4 h (December) to 16 h (August) and the average out-
door temperature varied from −3.1°C to 11.3°C. Over a third of 
the subject (38%) reported using medications known to induce 
sleep including antidepressants, benzodiazepines, and other 
sleep medications, and usage was higher in women (44%) than 
in men (27%). However, no relationship was found between the 
use of sleep medication and hours of daylight during the study.
Sleep
Patterns of sleep are presented in Table 1. Both men and 
women went to bed at around the same time (23:28 ± 61.9 min), 
but men arose earlier (08:15 ± 69.5 min vs. 08:51 ± 54.6 min, 
p < 0.01), leading to significantly shorter rest (529.4 ± 72.4 
vs. 557.6 ± 60.4 min/night, p < 0.01) and sleep durations 
(461.7 ± 79.9 vs. 486.9 ± 68.0 min/night, p < 0.01). Men awoke 
more often during sleep than women (46.5 ± 18.3 vs. 40.2 ± 15.7 
awakenings/night, p < 0.01). There were no gender differences 
in sleep efficiency, WASO, or onset latency.
Physical Activity
Cross-sectional PA data is presented in Table 1. Most subjects 
(> 85%) acquired ≥ 6 valid days of PA measurement. There 
were no significant differences between men and women in 
terms of valid days of wear, daily wear-time, daily activity 
counts, or counts per wear-time minute.
Predictors of Sleep Measures
The results of the backward-elimination multiple regression 
analyses are presented in Table 2. Both increases in age and 
in BMI were independently associated with a decrease in sleep 
efficiency and an increase in WASO. Age was also negatively 
associated with both bedtime and rise time, suggesting that, as 
age advances, individuals go to bed and rise earlier. The mul-
tiple regression analysis also confirmed the independent asso-
ciation between genders and rest and sleep duration, with men 
having shorter durations as a result of earlier rise times com-
pared to women. The analysis also confirmed that men had a 
greater number of awakenings during the night. Sleep medi-
cation usage was found to independently predict longer rest 
duration and onset latency and later rise and mid-sleep times, 
while diagnosed depression was found to significantly predict 
longer sleep duration and shorter onset latency. Higher daily 
PA was only found to be independently associated with earlier 
rise times. Interestingly, length of daylight was also found to 
independently predict rest and sleep duration and mid-sleep 
and rise times. On days with greater number of daylight hours, 
participants tended to have significantly shorter rest dura-
tions (β = −5.2 min/daylight h) and sleep durations (β = −4.1 
min/daylight h) and earlier rise times (β = −3.5 min/daylight 
h) and mid-sleep times (β = −1.9 min/daylight h). Addition-
ally, models pertaining to sleep timing and duration, including 
the mid-sleep and rise times and rest and sleep durations, had 
the highest adjusted R2 values and included both day length 
and gender as significant independent predictors. Neither self-
reported health status nor average outdoor temperature was 
found to independently predict any of the sleep outcomes.
Repeated Measures in a Subgroup
Demographic and Environmental Measures
Mean results for the subpopulation of 72 individuals who re-
peated the week long PA and sleep measurements during peri-
ods of longer (13.4 ± 1.4 h) and shorter day length (7.7 ± 1.8 h, 
p < 0.001) are displayed in Table 3. Sleep watch light sensor 
data indicated that participants were exposed to a greater daily 
amount of white light during periods of longer day length 
compared to those with shorter day length (221.0 ± 189.5 vs. 
82.3 ± 84.8 lux, respectively, p < 0.001). However, there were 
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Actiwatches during rest or sleep time between the 2 measure-
ment periods.
Physical Activity
When days were longer, participants had higher total PA counts 
(103,781 ± 58,777 vs. 95,152 ± 59,786 counts, p < 0.05) but 
also trended toward longer device wear-times (815.2 ± 79.4 vs. 
802.7 ± 67.2 min, p = 0.06). Consequently, there was no differ-
ence between periods of longer and shorter day lengths when 
PA was normalized for wear-time (125.6 ± 69.0 vs. 117.8 ± 73.1 
counts/wear-time min, respectively, p = 0.14).
Sleep
Results of the linear mixed effects model performed on the re-
peat subpopulation are summarized in Table 4. After control-
ling for demographic variables and environmental conditions 
in the linear mixed model, participants with repeat visits tended 
to rise earlier in summer months (β = −3.8 min/daylight hour, 
p < 0.01) but go to bed at approximately the same time (p > 0.05), 
leading to a shift toward earlier mid-sleep times (β = −2.2 min/
daylight hour, p < 0.01) and a reduced rest duration (β = −3.4 
min/daylight hour, p < 0.05). Sleep duration, sleep efficiency, 
sleep onset latency, WASO, and number of awakes were not 
found to vary significantly with hours of daylight. Similar to 
the cross-sectional results, gender also had a significant, inde-
pendent influence on sleep with women having longer onset 
latency (β = 16.7 min, p < 0.05) and later rise (β = 46.3 min, 
p < 0.01) and mid-sleep times (β = 18.9 min, p < 0.05) than men. 
Participants who used sleep medications were found to have a 
significantly longer rest duration (β = 38.8 min, p < 0.05) and 
later mid-sleep time (β = 23.1 min, p < 0.05). Physical activity 
was also found to have a small, but significant impact onset 
Table 1—Demographic, environmental, activity, and sleep parameter for cross-sectional population of older Icelandic adults. 
All Men Women p
n 244 110 134
Demographic and environmental
Age (y) 79.5 ± 4.8 (73.0–91.0) 79.7 ± 4.6 (74.0–91.0) 79.4 ± 4.9 (73.0–91.0) 0.65
Height (cm) 167.9 ± 9.4 (149.0–194.0) 175.9 ± 6.4 (160.0–194.0) 161.3 ± 5.6 (149.0–180.0) < 0.01
Weight (kg) 76.2 ± 16.0 (42–120) 82.7 ± 15.7 (54.0–120.0) 70.9 ± 14.3 (42.0–118.0) < 0.01
BMI (kg/m2) 26.9 ± 4.7 (15.6–42.8) 26.7 ± 4.4 (17.2–37.8) 27.2 ± 5 (15.6–42.8) 0.39
Self-reported health (1 excellent, 5 poor)* 2.6 ± 1.2 (1.0–5.0) 2.5 ± 1.2 (1.0–5.0) 2.7 ± 1.2 (1.0–5.0) 0.13
Anti-depressant usage (%) 11.1 10.0 11.9 0.63
Benzodiazepine usage (%) 11.9 9.1 14.2 0.22
Other sleep medication usage (%) 24.2 15.5 31.3 < 0.01
All sleep medication/anti-depressant usage (%) 37.7 27.3 43.6 < 0.01
Diagnosed depression (%)* 4.60 3.80 5.30 0.6
Daylight, h 10.3 ± 3.1 (4.4–16) 10.3 ± 3.0 (4.6–15.9) 10.3 ± 3.2 (4.4–16.0) 0.97
Outdoor temperature (°C) 4.9 ± 3.5 (−3.1–11.3) 4.5 ± 3.6 (−3.1–11.3) 5.2 ± 3.4 (−2.3–11.3) 0.09
Daily average white light exposure (lux) 158.9 ± 177.7 (3.4–984.5) 165.2 ± 182.6 (3.4–984.5) 153.8 ± 174.2 (3.7–826.8) 0.62
Rest time white light exposure (lux) 23.3 ± 45.9 (0.0–303.4) 21.1 ± 41.5 (0.0–220.8) 25.1 ± 49.4 (0.0–303.4) 0.50
Sleep time white light exposure (lux) 21.0 ± 45.6 (0.0–300.4) 19.0 ± 41.2 (0.0–220.1) 22.6 ± 49.0 (0.0–300.4) 0.55
Activity measures
Valid days of wear (> 10 h, n) 6.3 ± 0.9 (4–7) 6.4 ± 0.9 (4.0–7.0) 6.3 ± 0.9 (4.0–7.0) 0.57
Wear time (min) 830.2 ± 94.1 (641.5–1343.4) 835.2 ± 95.6 (645.5–1212.5) 826.1 ± 93.0 (641.5–1343.4) 0.45
Total counts (1000*counts/day) 109.0 ± 56.3 (14.2–349.7) 112.5 ± 58.5 (14.2–349.7) 106.1 ± 54.5 (19.5–288.2) 0.38
Wear time counts (counts/wear time min) 130.7 ± 65.1 (21.1–453.1) 133.9 ± 69.6 (21.1–453.1) 127.2 ± 61.9 (27.1–319.9) 0.43
Sleep measures
Sleep intervals (n) 7.0 ± 0.5 (5.0–12.0) 7.1 ± 0.7 (5.0–12.0) 7.0 ± 0.4 (6.0–10.0) 0.22
Rest duration (min) 544.9 ± 67.4 (276.4–764.4) 529.4 ± 72.4 (276.4–764.4) 557.6 ± 60.4 (416.3–740.3) < 0.01
Sleep duration (min) 475.5 ± 74.5 (190.7–741.8) 461.7 ± 79.9 (210.0–741.8) 486.9 ± 68 (190.7–662.1) < 0.01
Onset latency (min) 37.1 ± 31.5 (1.2–208.2) 34.4 ± 28.7 (1.3–157.6) 39.3 ± 33.6 (1.2–208.2) 0.18
Sleep efficiency (%) 81.6 ± 9.9 (36.5–99.2) 80.9 ± 10.1 (48.0–99.2) 82.2 ± 9.8 (36.5–97.2) 0.34
Waking after sleep onset (WASO) (min) 31.3 ± 17.3 (0.9–148.9) 33.0 ± 20.4 (0.9–148.9) 30.0 ± 14.3 (8.8–95.6) 0.18
Number of awakenings (n) 43.1 ± 17.2 (1.0–104.0) 46.5 ± 18.3 (1.0–104.0) 40.2 ± 15.7 (10.7–89.4) < 0.01
Bed time (hh:mm ± min) 23:28 ± 61.9 (19:49–03:49) 23:23 ± 55.9 (20:15–01:44) 23:33 ± 66.3 (19:49–03:49) 0.24
Rise time (hh:mm ± min) 08:35 ± 64.2 (05:11–11:51) 08:15 ± 69.5 (05:11–10:45) 08:51 ± 54.6 (05:59–11:51) < 0.01
Mid-sleep time (hh:mm ± min) 04:43 ± 34.2 (03:12–07:17) 04:33 ± 34.1 (03:12–06:22) 4:51 ± 31.9 (03:35–07:17) < 0.01
Data are presented as mean ± standard deviation (range) or percentage of participants. *n = 240 (All), 107 (Men), 133 (Women) for self-reported health 
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latency (β = 0.11 min/wear-time count, p < 0.05) and bed time 
(β = −0.18 min/wear-time count, p < 0.05). None of the other 
covariates such as age, BMI, health status, and diagnosed de-
pression, were found to influence sleep patterns or quality in 
the repeat subpopulation. Outdoor temperature was excluded 
as a covariate due to co-linearity with day length; however re-
sults did not change appreciably when it was included.
DISCUSSION
To our knowledge, this is the first study that used objective 
measurements of sleep and physical activity in a group of free-
living older men and women in a region where there is consid-
erable daylight variability throughout the year. We observed 
that this healthy Icelandic older population slept about 8 hours 
per night, with around 80% efficiency, and approximately 43 
awakenings per night. We also found that, on average, men 
rose about 35 minutes earlier than women, although bedtimes 
were similar across sexes (around 23:30), resulting in a sig-
nificantly shorter sleep duration for men (p < 0.01). The cross-
sectional analyses revealed some associations between sleep 
parameters and age, gender, BMI, PA levels, sleep medication 
use, and length of daylight. Using a subpopulation of 72 par-
ticipants who repeated the measurements during months with 
longer and shorter days, we were able to confirm the cross-
sectional finding that participants rose later in winter resulting 
in a longer time spent in bed.
In other studies where objective sleep monitors were used in 
generally healthy, older, free living populations, Blackwell, et 
al. reported similar sleep efficiency (78.1% ± 12.0%) in about 
3,000 community-dwelling men (76 ± 6 years, 90% Caucasian) 
in the US (6 sites).28 However, the total sleep time as measured 
by actigraphy was only 6.4 ± 1.2 hours in their sample, which 
is more than one hour less than the 7.7 ± 1.3 hours that we mea-
sured in Icelandic men. The WASO time in their study was 
78.4 ± 44.3 min, more than double the 33.0 ± 20.4 min found 
in our study. In studies focusing on older women, Spira et al. 
found the total sleep time was 409.2 ± 66.0 min (6.8 ± 1.1 h), 
sleep efficiency of 79.9% ± 9.9%, and WASO of 65.9 ± 40.4 
min in over 800 women with an average age of 82.4 years liv-
ing at their own homes in the US (4 different sites).8 Again, 
the Icelandic older women appeared to have longer total sleep 
times (487 ± 68 min or 8.1 ± 1.1 h) and about half of the WASO 
(30.0 ± 14.3 min). With differences between our Icelandic older 
population and the US studies being quite large, we could not 
discount the fact that both US studies used a different wrist-
worn actigraphy sleep watch (Sleepwatch-O by Ambulatory 
Monitoring Inc., Ardsley NY) than ours (Actiwatch Spectrum 
by Respironics). Weiss et al. performed a validation study com-
paring the Sleepwatch and Actiwatch simultaneous in a group 
of 30 adolescent participants and found near equivalent detec-
tions of total sleep time and sleep efficiency with significant 
correlation coefficient values.29 However, while the Blackwell 
and Spira studies used the proportional integration mode (PIM) 
for the Sleepwatch-O sleep/wake scoring given its higher cor-
relation to polysomnography measurements in older adults,30 
Weiss used the time-above-threshold (TAT) algorithm. In a 
more recent study, Lambiase et al. (2014) used an Actiwatch-
64m (also by Respironics) which uses the same accelerometer 
sensor and same data analysis software (Actiware), and found 
the total sleeping time in 121 healthy women (73.3 ± 1.7 years) 
in Pittsburgh PA to be 397 ± 53 min.22 This is closer to the previ-
ous US study, conducted by Spira8 than to our current results in 
Iceland, but the authors did not specify the sleep/wake detection 
parameters which may have influenced the results. Our results 
suggest that the total sleep time in these healthy, older Icelandic 
men and women were more than one hour longer than the US 
older people. Although sleep parameter definitions seem to be 
similar in all cases (e.g. total sleep time, WASO), it is still un-
clear what influence the monitor choice and various sleep detec-
tion algorithms may have had on these findings To the best of 
our knowledge, no similar data exist from other countries and 
regions to which we could further compare.
Table 2—Results of backward-elimination, multiple regression analysis of cross-sectional sleep parameters for AGES II cohort. 
Sleep Parameters* Adj. R2
Covariates†
Day Length BMI Female Age Activity Sleep Meds Depression
Std. β p Std. β p Std. β p Std. β p Std. β p Std. β p Std. β p
Rest duration 0.147 −0.24 < 0.01 – – 0.17 < 0.01 – – – – 0.23 < 0.01 – –
Sleep duration 0.070 −0.17 < 0.01 – – 0.18 < 0.01 – – – – – – 0.13 0.04
Onset latency 0.042 −0.12 0.06 – – – – – – – – 0.18 < 0.01 −0.14 0.03
Sleep efficiency 0.021 – – −0.14 0.04 – – −0.14 0.04 – – – – – –
WASO 0.047 – – 0.19 < 0.01 – – 0.18 < 0.01 – – – – – –
Number of awakenings 0.027 – – – – −0.18 0.03 – – – – – – – –
Bed time 0.024 – – – – – – −0.17 < 0.01 – – – – – –
Mid-sleep time 0.139 −0.17 < 0.01 – – 0.24 < 0.01 – – – – 0.21 < 0.01 – –
Rise time 0.136 −0.17 < 0.01 – – 0.25 < 0.01 −0.13 0.04 −0.14 0.02 – – 0.11 0.08
Separate models were used to evaluate each sleep parameter. Covariates included BMI, self-reported health status, gender, age, outdoor temperature, 
day length, sleep medication usage, diagnosed depression, and PA (activity counts/wear time). Data are presented as standardized Beta and p value. A 
negative standardized Beta value indicates an inverse relationship. *All models were adequately fit (p < 0.05). †Outdoor temperature and health status were 
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Another factor to consider in the interpretation of the re-
sults is the difference in the use of sleep medications amongst 
the populations studied. Over a third (38%) of the Icelandic 
participants studied reported using either a sleep-inducing 
medication or antidepressant (including 11% antidepressant 
use, 12% benzodiazepine use, and 24% other sleep medication 
use), which is a high percentage compared to the other studies 
mentioned (Lambiase22 reported 9% using sleep medication; 
Spira8 reported 7% antidepressant use and 4.8% benzodiaz-
epine use; Blackwell28 reported 7.9% antidepressant use, 4.5% 
benzodiazepine use, and 2.0% other sleep medication use). 
The participants in our study who reported use of these medi-
cations had longer sleep duration (488 ± 71 min with sleep 
medication vs. 468 ± 76 min without, p < 0.05), with a similar 
bedtime but a later rise time (08:50 vs. 08:27, p < 0.01) than 
participants who did not use sleep medication. Consequently, 
the high prevalence of sleep medication use may have contrib-
uted to the long sleep duration seen in this cohort. However, 
the average sleep duration in those participants not taking 
sleep medication (468 ± 76 min) was still longer than those 
reported in other studies. Additionally, sleep medication use 
had little influence on the measured quality of sleep, as us-
ers and non-users did not differ in sleep efficiency, number of 
awakenings, or WASO. When sleep medication use was in-
cluded as a covariate in the multiple linear regression analysis 
of the cross-sectional data, it was found to be a significant 
predictor of rest duration, onset latency, and rise time but had 
little influence on the contribution of the other independent 
Table 3—Demographic, environmental, activity, and sleep parameters for sub-population of participants with repeat visits 
during periods of longer and shorter day length. 
Demographics at first visit
n 72 (26 M, 46 F)
Age (y) 80.1 ± 5.1 (73–94)
Height (cm) 166.8 ± 8.5 (149.0–189.0)
Weight (kg) 74.9 ± 14.4 (44.0–115.0)
BMI (kg/m2) 27.0 ± 5.0 (17.0–42.8)
Self-reported health (1 excellent, 5 poor) 2.6 ± 1.2 (1.0–5.0)
Antidepressant usage (%) 13.9
Benzodiazepine usage (%) 18.1
Other sleep medication usage (%) 25.0
All sleep medication/antidepressant usage (%) 43.1
Diagnosed depression (%) 5.6
Summer Winter p
Environmental 
Day length (h) 13.4 ± 1.4 (9.9–15.9) 7.7 ± 1.8 (4.9–11.3) < 0.001
Outdoor temperature (°C) 7.9 ± 2.7 (1.9–11.3) 2.3 ± 2.7 (−3.4–6.1) < 0.001
Daily average white light exposure (lux) 221.0 ± 189.5 (16.2–826.8) 82.3 ± 84.8 (2.5–514.2) < 0.001
Rest time white light exposure (lux) 27.8 ± 43.7 (0.2–210.5) 28.7 ± 55.6 (0.1–227.0) 0.91
Sleep time white light exposure (lux) 24.7 ± 43.3 (0.1–210.5) 26.5 ± 54.7 (0.0–222.3) 0.82
Activity measures* 
Valid days of wear (> 10 h, n) 6.3 ± 0.9 (4.0–7.0) 6.4 ± 0.9 (4.0–7.0) 0.57
Wear time (min) 815.2 ± 79.4 (681.3–1041.0) 802.7 ± 67.2 (663.3–1022.0) 0.06
Total counts (1000*counts/day) 103.8 ± 58.8 (17.9–349.7) 95.2 ± 59.8 (16.3–30.8) < 0.05
Wear time counts (counts/wear time min) 125.6 ± 69.0 (24.1–453.1) 117.8 ± 73.1 (22.2–401.5) 0.14
Sleep measures
Rest duration (min)† 539.0 ± 72.0 (371.6–687.2) 554.8 ± 69.6 (330.9–689.0)
Sleep duration (min) 464.8 ± 78.9 (190.7–642.4) 473.8 ± 66.3 (301.8–635.3)
Onset latency (min) 39.5 ± 34.1 (4.4–208.2) 45.2 ± 34.6 (3.7–155.3)
Sleep efficiency (%) 80.4 ± 10.1 (36.5–91.8) 79.3 ± 8.5 (56.8–93.8)
Waking after sleep onset (WASO) (min) 32.1 ± 15.5 (7.3–99.4) 35.7 ± 20.4 (9.3–116.6)
Number of awakenings (n) 45.5 ± 17.2 (13.0–104.0) 47.3 ± 8.4 (16.4–125.1)
Bed time (hh:mm ± min) 23:34 ± 68.7 (20:15–03:49) 23:39 ± 77.3 (20:52–05:16)
Rise time (hh:mm ± min)† 08:34 ± 67.9 (05:11–11:51) 08:55 ± 62.4 (06:08–10:47)
Mid-sleep time (hh:mm ± min)† 04:44 ± 39.1 (03:12–07:17) 04:57 ± 37.8 (03:45–08:01)
Data are presented as mean ± standard deviation (range) or percentage of participants. *n = 70 (25 M, 45 F) for Activity measures; †Sleep measures found 
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predictors of sleep patterns and quality, such as day length, 
gender, age, or PA.
If this was indeed a healthier study population than those 
from the US, the PA measured by the hip-worn accelerometer 
on the Icelandic women (127 ± 62 ct/min/day) contradictorily 
appeared to be much less than that measured from the group 
studied by Lambiase22 from the Healthy Women Study (HWS) 
cohort in Pittsburgh, PA, USA,31 where the average daily activ-
ity was reported to be 190 ct/min/day. One explanation for this 
PA discrepancy is the difference in the age of the subjects. The 
women enrolled in the Pittsburgh HWS were on average about 
6 years younger than those in the current study, and age-related 
declines in PA have been documented in similar older popu-
lations.32,33 However, in a similar study of older adults living 
in urban areas in the UK with a closer mean age to the par-
ticipants in our study (77.7 ± 5.8 years for men and 78.6 ± 5.7 
years for women), Davis33 also reported higher daily wear-time 
activity counts than those observed in our population (198 ± 117 
vs. 134 ± 70 ct/min/day for men and 163 ± 116 ct/min/day vs. 
127 ± 62 ct/min/day for women). Other factors that may influ-
ence the reported physical activity may be the activity monitor 
type and the data processing methods used in each of the stud-
ies; however, the older Actigraph GT1M monitor used in both 
the Lambiase22 and Davis33 studies has been shown to be com-
parable to the newer GT3X monitors used in the current study.34 
Each of the studies used different methods to determine moni-
tor wear-time, which may have a small impact on the results. 
However, the wear time reported by Davis33 (13.9 h for women 
and 14.4 h for men) was similar to what we have reported (13.8 
h for women and 13.9 h for men); wear time in the Lambiase 
study22 was not reported. It is possible that subjects in our Ice-
landic cohort achieved more activity than the other groups 
during non-wear periods by performing water sports such as 
swimming, given that roughly one-quarter of the AGES cohort 
who received an accelerometer reported swimming for exercise 
both in summer and winter25; however, we do not have suffi-
cient information from other studies to confirm this conjecture.
We also found that total hours of daylight were statistically 
significantly related to sleep timing and duration but were not 
associated with sleep quality or physical activity patterns. Spe-
cifically, shorter days were associated with the later mid-sleep 
and rise times leading to longer rest and sleep durations in both 
the cross-sectional analysis of 244 participants and in the 72 
participant subgroup which repeated the week long sleep as-
sessments. However, the absolute sleep duration differences 
between the two measurement periods were only about 20 
minutes (4.3 min/daylight hour). Furthermore, no differences 
were observed in the total sleep time, WASO, sleep efficiency, 
or wear-time PA level during the winter, suggesting that the 
older population studied here is able to adapt sleeping and phys-
ical activity patterns to accommodate the change in daylight 
across seasons. In fact, the comparable Actiwatch Spectrum 
white-light sensor readings during sleep- or rest-time between 
darker and lighter months seem to support this rationale (Table 
3). However, data from the light sensor should be interpreted 
with caution, however, since the sensor may have become ob-
structed by heavy blankets or clothing35 and the variability of 
light sensor measurements between devices has been shown 
to be significant36 and they were not calibrated prior to use, as 
in other studies using the Spectrum.37 Further, due to device 
memory and data use constraints, we were limited to collecting 
broad spectrum white light rather than the red, green, and blue 
spectral components which may have been helpful in differen-
tiating the contributions of natural and artificial light sources 
to the daily patterns of light exposure.38 It has also been shown 
that, after a bout of increased light exposure, older adults have a 
diminished cognitive response,16 reduced subjective changes in 
alertness and sleepiness,17 an absence of increased PER2 clock-
gene expression,39 and reduced circadian responsiveness13 as 
compared to younger subjects. These blunted responses in older 
subjects may be due to reduced corneal light exposure as a re-
sult of changes in pupil size40 and lens opacity13 that occur with 
advancing age, which may also help explain the small seasonal 
differences in sleep patterns observed in this study.
Table 4—Results of a linear mixed models regression analysis of sleep parameters for the sub-population of participants with 







Day Length Female Activity Sleep Meds
β SE p β SE p β SE p β SE p
Rest duration 0.16 0.70 −3.37 1.10 < 0.01 14.92 16.05 0.36 0.15 0.10 0.14 38.77 16.36 0.02
Onset latency 0.10 0.54 −1.25 0.66 0.06 16.71 7.70 0.03 0.11 0.05 0.04 5.82 7.88 0.46
Bed time 0.08 0.88 −0.38 0.73 0.61 30.69 18.50 0.10 −0.18 0.09 0.04 −18.35 18.66 0.33
Mid-sleep time 0.23 0.82 −2.22 0.48 < 0.01 18.94 8.75 0.03 0.04 0.05 0.38 23.09 8.88 0.01
Rise time 0.20 0.80 −3.79 0.84 < 0.01 46.29 14.95 < 0.01 0.004 0.09 0.96 21.28 15.18 0.17
Separate models were used to evaluate each sleep parameter. Fixed effects covariates included BMI, self-reported health status, gender, age, day length, 
sleep medication usage, diagnosed depression, and physical activity (activity counts/wear time). The subject identifier was used as the random effects 
variable. Data are presented as Beta, standard error (SE) and p value for significant fixed effects covariates. The marginal R2 (Marg. R2) is the variance 
explained by fixed effects alone; the conditional R2 (Cond. R2) is the variance explained by both fixed and random effects. A negative Beta value indicates 
an inverse relationship; significant relationships (p < 0.05) are bolded. *Results for sleep parameters with no significant predictors (sleep duration, sleep 
efficiency, number of awakenings, and wake after sleep onset) are not presented. †Body mass index (BMI), health status, age, and diagnosed depression 
status were not significant independent predictors of any sleep parameters tested and are not shown in the table. Outdoor temperature was excluded as a 
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We cannot rule out the idea that the seasonal difference 
may be due to a difference in the outdoor temperature or pre-
cipitation rather than the difference in daylight hours, as the 
difference in outdoor temperature was found to differ signifi-
cantly between the two study visits. However, when outdoor 
temperature was included as a covariate in the cross-sectional 
regression model and the repeat participant mixed model 
analysis it was not found to independently predict any of the 
sleep parameters. Also, the variation in outdoor temperature 
and precipitation from summer to winter in Reykjavik, Ice-
land is known to be slight relative to other locations of similar 
latitude. For instance, the variation in temperature in Reykja-
vik (average winter month low of −3°C and average summer 
month high of 13.3°C, a range of 16.3°C) is closer to that of 
San Francisco (37.8°N with a low of 7.6°C to a high of 21.2°C 
high, range of 13.6°C, one of the lowest in the continental US) 
than to Stockholm, Sweden (59°N, −5°C low to 22°C high, a 
27°C difference).41
Our findings regarding sleep patterns and the length of day-
light was similar to a Norwegian population study conducted 
by Sivertsen,42 where the latitude was equal to that of Iceland. 
In that population study of over 43,000 participants, their self-
reported time in bed was not related to the length of daylight 
(or month). Conversely, a self-report study conducted by Fri-
borg14 examined summer and winter sleep patterns in 150 Nor-
wegian (69°N) and 180 Ghanese (5°N) men and women and 
found that the Norwegians rose 32 min later, had longer onset 
latency, and slightly reduced sleep efficiency but no change in 
total sleep time in winter, while sleep patterns of the Ghanese 
were unchanged from winter to summer. The results of the 
Friborg study, as well as our own, reflect some of the shifts 
in circadian profile found in laboratory-based light exposure 
studies.13 It is worth mentioning, however, the average age of 
the study participants in the Sivertsen42 study was 44.6 years 
and in the Friborg14 study was 25.4 years for the Ghanese and 
22.7 years for Norweigans, and we could not ascertain any sub-
groups that have a comparable age to our subjects (about 80 
years). Additionally our assessments of free-living sleep pat-
terns and quality used an objective monitor, which often differ 
from subjective self-reports.43–45
One of the strengths of the current study was the inclusion 
of a generally healthy population of older men and women liv-
ing in Iceland who were part of a longitudinal study which 
included detailed assessments of their health status over the 
past 45 years. Additionally, we were able to simultaneously 
measure one week of free-living sleep and PA using objective 
wrist- and hip-worn accelerometers, respectively, with high 
compliance rate (nearly 100% with 6+ days of sleep and 79% 
with 6+ days for PA). Concordant measurement of objective 
sleep and hip-worn PA is rare, particularly in older popula-
tions.22 And, unlike previous studies, we were able to compare 
the sleep patterns and qualities between men and women, and 
explore multiple factors that are thought to influence sleep. 
Due to Iceland’s unique geographical location, which provided 
a relatively large variation in daylight, we were able to investi-
gate the relationship between day length and free-living sleep-
patterns in older adults more extensively. We were also able to 
use within-individual comparisons of sleep and PA patterns 
gained by repeating measurements in an opposite daylight 
condition to confirm cross-sectional findings that season had a 
statistically significant, although practically minor impact on 
sleep patterns and quality in this population.
A limitation of the current study is that while age, gender, 
length of daylight, BMI, and PA levels were independently 
associated with cross-sectional differences in sleep patterns 
(bed time, rise time, rest and sleep durations) and sleep quality 
(total sleep time, efficiency, WASO, and number of awaken-
ings), we could not state with certainty that any causal rela-
tionships exist. Studying a mostly healthy population may 
have limited our ability to draw conclusions that relate health 
status to sleep patterns and it does not permit us to investi-
gate other important relationships between sleep and health 
in patients with clinical conditions common to older individu-
als. Thus, the question of whether sleep patterns and qual-
ity impact future health remains to be answered with further 
follow-up in this cohort and in future studies that are designed 
to address these questions. Moreover, the cohort that we stud-
ied consisted of subjects between 73 and 91 years of age. The 
older age and healthy status could partly explain the longer 
sleep time and limited influence by outdoor daylight varia-
tions. The usage of sleep medication was high in the Icelandic 
population we studied and, along with the health status, was 
assessed using self-report during the participants’ first visit. 
Therefore, it is not known whether the participants changed 
medication usage, or health status, between visits. However, 
in the cross-sectional sample, neither sleep medication use 
nor health status was related to day length, suggesting that it 
may be consistent throughout the year. Additionally, subjects 
who repeated the one-week measurements did not necessar-
ily wear the same sleep-watch or hip-worn PA monitor, due 
to logistical limitations. This may have contributed to some 
variability in sleep, PA, and light measurements across study 
periods. Lastly, we only analyzed the night sleeping patterns 
and excluded naps.
In conclusion, our study of objectively measured free-
living sleep and physical activity in older Icelandic men and 
women revealed that this population had a relatively long sleep 
time (about 8 h in women, and 7.7 h for men), lower average 
nightly awakenings, but higher use of sleep medications than 
most previous reports from similarly older populations. Age 
and BMI were found to have the greatest association with 
the quality of sleep and men were found to rise earlier and 
sleep fewer minutes per night than women. The statistically 
significant but small changes in sleep patterns and quality 
observed during periods of disparate daylight length suggest 
that this population is well adapted to the seasonal variation 
of daylight in Iceland.
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